New option for ICU patients who Won't settle with standard sedatives
NCT ID NCT07457593
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program offers inhaled isoflurane, given through a special device, to sedate adult ICU patients on breathing machines who are difficult to sedate with usual IV medicines. It aims to help patients who remain agitated or at risk of harming themselves despite standard treatments. The goal is to improve comfort and safety for these critically ill individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults ≥18 years of age; * Receiving invasive mechanical ventilation and continuous sedation in the ICU; * Inability to maintain a target sedation level ensuring patient comfort and safety with conventional intravenous sedatives, in clinically appropriate combinations and at maximum tolerated doses, despite optimized analgesia and ventilator settings, with 1. recurring episodes of agitation or self-harm, such as attempting or actual removal of an endotracheal tube or of indwelling catheters or monitors, or necessitating physical restraints; or 2. escalating sedative and opioid drug doses, despite mitigating strategies (e.g., sedative drug combinations or rotation to reduce toxicity); or 3. clinical concerns for, or indications of, serious untoward effects of ongoing conventional intravenous sedation and analgesia agents (e.g., hypertriglyceridemia, propofol-related infusion syndrome, bradycardia, iatrogenic withdrawal syndrome); and * No other available sedative option is considered appropriate * Is not currently enrolled in or is eligible for a clinical study that would prohibit the participation in this EAP. Exclusion Criteria: * Ventilator tidal volume \<200 or \>1000 mL * Need for high frequency oscillation ventilation (HFOV) or high frequency percussive ventilation (HFPV) * Comfort care only (end of life care); * Suspected but unmonitored elevated intracranial pressure (e.g., patients with acute stroke, severe head trauma, meningitis without ICP monitoring); * Contraindication to isoflurane, including: 1. Known or suspected personal or family history of malignant hyperthermia (MH) or high risk for MH or acute drug-induced muscle injury (eg, muscular dystrophies); 2. Severe hemodynamic compromise; 3. Known hypersensitivity reaction to isoflurane or other halogenated volatile anesthetic agents * History of ventricular tachycardia/Long QT Syndrome; * Female patients who are pregnant or breast-feeding; * Imperative need for continuous active humidification through mechanical ventilation circuit; * Any medical conditions, that, in the Investigator´s opinion, would impose excessive risk to the patient or would adversely affect the patient's participation in the EAP; * Inability to obtain informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Sedation are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a small dose of ketamine make colonoscopy sedation safer?
- Can a gentle oxygen boost make lung biopsies safer and faster?
- A Mother's voice as medicine? trial tests comforting effect on ventilated children
- A single score may spot breathing trouble before it's too late in sedated children
- New sedation cocktail aims to protect elderly patients during routine scopes
- Which sedation drug is safer for mom and baby during C-Section?